Clinical Trial Detail

NCT ID NCT03704688
Title Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

lung adenocarcinoma

Therapies

Ponatinib + Trametinib

Age Groups: adult senior

Additional content available in CKB BOOST